Top compounds associated with response to PRUNE2


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.11 0.002
mRNA PD318088 CTRPv2 pan-cancer AAC -0.12 0.002
mRNA BRD-K20514654 CTRPv2 pan-cancer AAC 0.17 0.002
mRNA leptomycin B CTRPv2 pan-cancer AAC -0.11 0.002
mRNA Doxorubicin GDSC1000 pan-cancer AAC -0.11 0.002
mRNA Topotecan CCLE pan-cancer AAC -0.14 0.002
mRNA Bosutinib CTRPv2 pan-cancer AAC -0.11 0.002
mRNA GSK2126458 GDSC1000 pan-cancer AAC -0.099 0.002
Download CSV